title: Burning mouth syndrome: a review and update.
abstract: Burning mouth syndrome (BMS) is mainly found in middle aged or elderly women and is characterized by intense burning or itching sensation of the tongue or other regions of the oral mucosa. It can be accompanied by xerostomia and dysgeusia. The syndrome generally manifests spontaneously, and the discomfort is typically of a continuous nature but increases in intensity during the evening and at night. Although BMS classically has been attributed to a range of factors, in recent years evidence has been obtained relating it peripheral (sensory C and/or trigeminal nerve fibers) or central neuropathic disturbances (involving the nigrostriatal dopaminergic system). The differential diagnosis requires the exclusion of oral mucosal lesions or blood test alterations that can produce burning mouth sensation. Patient management is based on the avoidance of causes of oral irritation and the provision of psychological support. Drug treatment for burning sensation in primary BMS of peripheral origin can consist of topical clonazepam, while central type BMS appears to improve with the use of antidepressants such as duloxetine, antiseizure drugs such as gabapentin, or amisulpride.
authors.affiliation: Universidad de Valencia, 46071 Valencia, Espana.
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Silvestre
authors.forename: Javier
authors.initials: J
authors.lastname: Silvestre-Rangil
authors.forename: Pía
authors.initials: P
authors.lastname: López-Jornet
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000465:Algorithms; D000077582:Amisulpride; D000928:Antidepressive Agents / Q000627:therapeutic use; D002054:Burning Mouth Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D002998:Clonazepam / Q000627:therapeutic use; D003677:Deficiency Diseases / Q000150:complications; D003778:Dentures / Q000009:adverse effects; D000068736:Duloxetine Hydrochloride / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008593:Menopause; D008875:Middle Aged; D019964:Mood Disorders / Q000453:epidemiology; D036421:Nerve Fibers, Unmyelinated / Q000502:physiology; D009967:Orthodontic Appliances; D017678:Sex Distribution; D013469:Sulpiride / Q000031:analogs & derivatives / Q000627:therapeutic use; D014061:Tongue Habits
chemical_list: D000928:Antidepressive Agents; D002998:Clonazepam; D013469:Sulpiride; D000077582:Amisulpride; D000068736:Duloxetine Hydrochloride